Balance Sheet - Core Scientific, Inc./tx (CORZ)
$(Billion, Million)| Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 311.38 | 860.09 | 52.69 | 15.88 | 117.87 | 8.67 | 6.66 |
| Accounts receivable, net | 337.16 | 1.03 | 7.16 | 0.26 | 1.68 | 1.11 | 0.29 |
| Inventories | -6.16 | 58.31 | |||||
| Other current assets | 584.16 | 66.74 | 39.45 | 4.01 | 637.01 | 61.14 | 4.11 |
| Total current assets | 895.54 | 903.96 | 97.02 | 85.10 | 756.56 | 70.92 | 11.05 |
| Total non-current assets | 1,452.11 | 694.85 | 615.14 | 722.58 | 1,682.30 | 154.66 | 150.96 |
| Total assets | 2,347.64 | 1,598.82 | 712.16 | 807.69 | 2,438.86 | 225.58 | 162.01 |
| Total current liabilities | 781.40 | 134.56 | 488.42 | 186.79 | 320.29 | 69.65 | 19.47 |
| Total non-current liabilities | 2,528.98 | 2,284.43 | 820.67 | 1,030.24 | 777.37 | 22.23 | 6.69 |
| Total liabilities | 3,310.38 | 2,419.00 | 1,309.10 | 1,217.03 | 1,097.65 | 91.88 | 26.16 |
| Total stockholders' equity | -962.74 | -820.18 | -596.94 | -409.35 | 1,341.21 | 133.70 | 135.86 |
| Common shares outstanding | 318 | 256 | 380 | 375 | 233 | 380 | 380 |
Show Quarterly Balance Sheet
Balance Sheet - Core Scientific, Inc./tx (CORZ)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 1,005.15 | 311.38 | 453.44 | 754.12 | 778.59 | 860.09 | 253.80 | 96.12 | 98.13 | 52.69 | 64.50 | 77.08 | 47.49 | 15.88 | 29.55 | 128.54 | 96.36 | 117.87 | 147.91 |
| Accounts receivable, net | 337.16 | 250.64 | 1.02 | 1.03 | 6.24 | 4.68 | 1.11 | 7.16 | 2.01 | 2.26 | 0.18 | 0.26 | 3.07 | 3.52 | 0.51 | 1.68 | 0.86 | ||
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||
| Other current assets | 449.68 | 584.16 | 607.59 | 172.77 | 134.22 | 66.74 | 18.59 | 17.07 | 44.09 | 39.45 | 68.21 | 31.86 | 52.53 | 1.03 | 180.95 | 379.50 | 711.38 | 637.01 | 608.20 |
| Total current assets | 1,454.83 | 895.54 | 1,061.03 | 1,004.76 | 833.18 | 903.96 | 277.86 | 117.86 | 143.32 | 97.02 | 134.72 | 111.20 | 100.20 | 85.10 | 213.57 | 511.56 | 808.25 | 756.56 | 756.97 |
| Total non-current assets | 1,614.73 | 1,452.11 | 1,234.95 | 973.29 | 792.19 | 694.85 | 644.00 | 643.59 | 670.65 | 615.14 | 570.74 | 639.67 | 659.82 | 722.58 | 1,190.43 | 1,333.60 | 1,895.80 | 1,682.30 | 1,349.58 |
| Total assets | 3,069.56 | 2,347.64 | 2,295.98 | 1,978.05 | 1,625.37 | 1,598.82 | 921.85 | 761.46 | 813.97 | 712.16 | 705.46 | 750.86 | 760.02 | 807.69 | 1,404.00 | 1,845.16 | 2,704.05 | 2,438.86 | 2,106.55 |
| Total current liabilities | 2,661.78 | 781.40 | 669.86 | 562.72 | 195.51 | 134.56 | 76.51 | 74.82 | 138.15 | 488.42 | 312.66 | 187.37 | 302.23 | 186.79 | 1,289.01 | 516.55 | 414.69 | 320.29 | 297.74 |
| Total non-current liabilities | 1,713.47 | 2,528.98 | 2,754.08 | 2,480.01 | 1,611.37 | 2,284.43 | 1,574.73 | 1,770.51 | 994.33 | 820.67 | 811.53 | 955.93 | 866.55 | 1,030.24 | 41.97 | 912.15 | 1,162.65 | 777.37 | 475.45 |
| Total liabilities | 4,375.25 | 3,310.38 | 3,423.94 | 3,042.73 | 1,806.88 | 2,419.00 | 1,651.25 | 1,845.33 | 1,132.48 | 1,309.10 | 1,124.19 | 1,143.30 | 1,168.78 | 1,217.03 | 1,330.97 | 1,428.71 | 1,577.34 | 1,097.65 | 773.18 |
| Total stockholders' equity | -1,305.69 | -962.74 | -1,127.96 | -1,064.68 | -181.51 | -820.18 | -729.40 | -1,083.87 | -318.51 | -596.94 | -418.73 | -392.44 | -408.76 | -409.35 | 73.03 | 416.45 | 1,126.71 | 1,341.21 | 1,333.37 |
| Common shares outstanding | 323 | 318 | 319 | 318 | 363 | 306 | 292 | 288 | 283 | 385 | 382 | 376 | 375 | 375 | 354 | 325 | 307 | 272 | 237 |